Pharmosa Biopharm (ROCO:6875) Pretax Margin %: -233.60% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6875 Pharmosa Biopharm Inc ROCO:6875
11 GF Score
Price NT$35.55
! 1 Warning Sign
View Full Analysis

What is Pharmosa Biopharm Pretax Margin %?

Pharmosa Biopharm ROCO:6875 +0.14% 11 Pretax Margin % is -233.60% as of Dec. 2025. GuruFocus rates ROCO:6875 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 941 Biotechnology companies, Pharmosa Biopharm ranks worse than 71.84% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Pharmosa Biopharm's Pre-Tax Income for the three months ended in Dec. 2025 was NT$-111.18 Mil. Pharmosa Biopharm's Revenue for the three months ended in Dec. 2025 was NT$47.59 Mil. Therefore, Pharmosa Biopharm's pretax margin for the quarter that ended in Dec. 2025 was -233.60%.

The historical rank and industry rank for Pharmosa Biopharm's Pretax Margin % or its related term are showing as below:

ROCO:6875' s Pretax Margin % Range Over the Past 10 Years
Min: -570.63   Med: -99.45   Max: 2.69
Current: -570.63

ROCO:6875's Pretax Margin % is ranked worse than
71.84% of 941 companies
in the Biotechnology industry
Industry Median: -89.42 vs ROCO:6875: -570.63

Pharmosa Biopharm  (ROCO:6875) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Pharmosa Biopharm Pretax Margin % Related Terms

Pharmosa Biopharm Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Pharmosa Biopharm's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmosa Biopharm Pretax Margin % Chart

Pharmosa Biopharm Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
Get a 7-Day Free Trial 0.00 0.00 2.69 -99.45 -570.63

Pharmosa Biopharm Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.84 0.00 -854.04 -1,147.40 -233.60

ROCO:6875 vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Pharmosa Biopharm's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmosa Biopharm Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmosa Biopharm's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Pharmosa Biopharm's Pretax Margin % falls into.


ROCO:6875
11GF Score
Pharmosa Biopharm Inc ROCO:6875
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmosa Biopharm Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Pharmosa Biopharm's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-383.849/67.268
=-570.63 %

Pharmosa Biopharm's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-111.18/47.594
=-233.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -233.60% mean?
Pharmosa Biopharm (ROCO:6875) has a Pretax Margin % of -233.60% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pharmosa Biopharm and its competitors. According to the industry distribution chart, Pharmosa Biopharm ranks #676 out of 941 companies in the Biotechnology industry, placing it in the top 71.8%.
Is Pharmosa Biopharm's Pretax Margin % too high?
Pharmosa Biopharm's current Pretax Margin % is -233.60%. Based on the distribution chart, Pharmosa Biopharm ranks #676 out of 941 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Pharmosa Biopharm has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Pharmosa Biopharm's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pharmosa Biopharm ranks #676 out of 941 companies for Pretax Margin %. This places Pharmosa Biopharm in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pharmosa Biopharm and its competitors. Pharmosa Biopharm's current Pretax Margin % is -233.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmosa Biopharm stock overvalued right now?
Pharmosa Biopharm (ROCO:6875) has a current Pretax Margin % of -233.60%. The current Pretax Margin % is -233.60%. Pharmosa Biopharm's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Pharmosa Biopharm (ROCO:6875), the current Pretax Margin % is -233.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmosa Biopharm Business Description

Address No. 508, Sec. 7, Zhongxiao E. Road, 11th Floor / 11th Floor-1, Nangang District, Taipei, TWN
Pharmosa Biopharm Inc is a world-class biotechnology company. The Company's principal business activities comprise the development and commercialization of inventive biopharmaceutical drugs. Its product portfolio includes sustained-release dosage forms and drug-device combination products intended for home based therapies.
11GF Score

Get the complete analysis for ROCO:6875

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$35.55
Price